Latest Breaking News On - Chronic obstructive pulmonary - Page 4 : comparemela.com

Chiesi's carbon minimal inhalers reach innovation milestone as phase III trials now underway

Chiesi, the international research-focused biopharmaceutical and healthcare group, has announced that its phase III clinical safety trial for the development of an innovative carbon minimal inhaler platform is underway.1 The carbon minimal inhaler will replace the current hydrofluorocarbon propellant (HFC 134a) .

The VA has vowed to fix how veterans receive disability benefits for this burn pit injury. Critics say it's taking too long

Because the VA does not have a specific diagnostic code for constrictive bronchiolitis, most veterans with this condition are not awarded disability compensation. But a new revision to the system could change that.

Hamilton Medical Center Receives National, Regional, State And Local Recognition For Medical Excellence

Dose-Escalation, Low-Dose Regimens May Improve Roflumilast Treatment Adherence in Patients With COPD

This study suggests that dose-escalation or low-dose regimens for roflumilast treatment in patients with chronic obstructive pulmonary disease (COPD) may improve adherence.

HMC receives recognition for excellence

DALTON – Hamilton Medical Center (HMC) was recently recognized for medical excellence and patient safety quality by CareChex®. HMC was ranked in the top 10 percent in the nation in